Peregrine Pharma (PPHM) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Total costs and expenses: 16.69M
Today's EPS Names:
OCCI, PMCB, BRID, More
Financial Fact:
Total costs and expenses: 16.69M
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q3 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $6.71 million versus the consensus estimate of $7.96 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler sees Google TPU sales hitting $104BN by 2028
- PB Fintech Limited (POLICYBZ:IN) PT Lowered to INR1,425 at Investec
- BGC Group reaffirms Q3 2026 revenue and earnings outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
